Distribution and Phenotype of Epstein-Barr Virus-infected Cells in Inflammatory Bowel Disease
Overview
Affiliations
Little is known about Epstein-Barr virus (EBV) infection of colon mucosa, particularly in inflammatory bowel diseases. Crohn's disease and ulcerative colitis are thought to differ in T-helper lymphocyte composition and cytokine secretion patterns. Some of the implicated cytokines are growth factors for EBV-infected cells. We examined colon mucosa for differences in the distribution and phenotype of EBV-infected cells. Colon tissues with Crohn's disease (n = 31) or ulcerative colitis (n = 25) and controls (n = 60) were characterized by in situ hybridization and immunohistology for six EBV gene products as indicators of latent and replicative EBV infection. The cells were additionally phenotyped by combined detection of the EBV transcripts and B- or T-cell antigens. B lymphocytes predominated as the site of latent EBV infection in the colon and were most numerous in ulcerative colitis. In active ulcerative colitis, EBV-positive lymphocytes accumulated under and within the epithelium and displayed evidence for replicative infection. The patterns of mucosal EBV gene expression indicate local impairment of virus-specific T-cell responses in active ulcerative colitis. Detection of EBV may help to discriminate between active ulcerative colitis and other inflammatory bowel diseases. Colon mucosa is a potential site of EBV replication and may be relevant for EBV transmission.
Zarenezhad E, Abdulabbas H, Kareem A, Kouhpayeh S, Barbaresi S, Najafipour S Arch Microbiol. 2023; 205(6):252.
PMID: 37249707 PMC: 10228462. DOI: 10.1007/s00203-023-03590-0.
Impact of Epstein-Barr virus infection in patients with inflammatory bowel disease.
Zhang H, Zhao S, Cao Z Front Immunol. 2022; 13:1001055.
PMID: 36389673 PMC: 9651941. DOI: 10.3389/fimmu.2022.1001055.
Epstein-Barr Virus in the Development of Colorectal Cancer (Review).
Oleynikova N, Danilova N, Grimuta M, Malkov P Sovrem Tekhnologii Med. 2021; 13(4):82-91.
PMID: 34603767 PMC: 8482827. DOI: 10.17691/stm2021.13.4.09.
Epstein-Barr Virus DNA Exacerbates Colitis Symptoms in a Mouse Model of Inflammatory Bowel Disease.
Andari S, Hussein H, Fadlallah S, Jurjus A, Shirinian M, Hashash J Viruses. 2021; 13(7).
PMID: 34210024 PMC: 8310145. DOI: 10.3390/v13071272.
as a Model System to Assess the Effect of Epstein-Barr Virus DNA on Inflammatory Gut Diseases.
Madi J, Al Outa A, Ghannam M, Hussein H, Shehab M, Hasan Z Front Immunol. 2021; 12:586930.
PMID: 33828545 PMC: 8019809. DOI: 10.3389/fimmu.2021.586930.